You are on page 1of 4

Ireka Corporation

Recommendation: HOLD
Stock Code: 8834 Bloomberg: IREKA MK Price: MYR0.84 12-Month Target Price: MYR0.94 Date: July 26, 2010

Board: Main Pr i ce 30 Day Movi ng Aver age Price (MYR)


2.00

Sector: Construction 1.80

1.60
GICS: Industrials/Construction & Engineering 1.40

Market Value - Total: MYR95.7 mln 1.20

1.00

0.80

0.60
Summary: Ireka is a construction, engineering and property 0.40
development and investment company with assets primarily
in Malaysia and Vietnam. Vol ume Vol ('000)
2,000
1,600
Analyst: Kum Seng, Wan 1,200
800
400
0
Jul 07 Sep 07 Dec 07 Feb 08 Apr 08 Jun 08 Sep 08 Nov 08 Jan 09 Mar 09 May 09 Aug 09 Oct 09 Dec 09 Feb 10 Apr 10 Jul 10

Recent Developments Recommendation & Investment Risks


 Ireka’s 23%-associate, Aseana Properties Ltd (ASPL LN, USD0.49,  We lower our recommendation on Ireka to Hold (from Buy), but lift our
Not Ranked) is selling its 50% stake in a 20-storey office tower and a 12-month target price to MYR0.94 (from MYR0.88).
five-storey retail mall (inclusive of car parks) at the 1 Mont Kiara
Development to ARA Asia Dragon Fund for USD104 mln (MYR333  We lower Ireka’s recommendation to Hold as the recent 12% surge in
mln). The sale is expected to be completed by end-2010 and is its share price has left its prospective FY11 and FY12 PERs of 10.7x
conditional upon the issuance of a Certificate of Occupation. and 8.6x respectively within the 8x-11x peer average range of small-to
medium-sized contractors within our coverage. We believe the jump in
 Although Aseana reasoned that the disposal is to realize the value of Ireka’s share price was driven by expectations that Aseana will return
its investment in the development, it is expected to record a net loss of the excess funds from the disposal to its shareholders in the form of a
USD4.0 mln (MYR12.8 mln) from the disposal as the selling price is special dividend. However, no decision has been made as Aseana is
below the property’s net asset value. also considering other options, including share buy backs or investing
in new developments or current developments that will enhance future
 After imputing its share of Aseana’s loss on disposal of MYR2.9 mln, returns. Consequently, we think hopes for a special dividend are
we trim Ireka’s FY11 (Mar) net profit forecast to MYR8.9 mln (from premature and no special dividends from Aseana have been imputed
MYR11.8 mln). Our FY12 profit estimate is unchanged. into our model.

 Our 12-month target price remains derived from a blend of historical


Earnings Outlook and relative price ratios, where we ascribe unchanged P/B of 0.8x,
P/Sales of 0.3x, relative PER target multiple of 9x on its FY12 (rolled
 Ireka’s unbilled construction orderbook of MYR440 mln will continue to over from FY11) earnings and by discounting expected dividend
underpin its FY11 earnings, with margins likely to remain stable with payments using the dividend discount model (unchanged WACC of
few cost pressures. With most of its ongoing projects completing in 10.5% and terminal growth rate of 3%). We also included an
FY11, the construction start of a MYR272 mln high-end condominium unchanged net EPS estimate of 4.0 sen to arrive at our target price.
in the KLCC precinct in mid-2011 will anchor its construction earnings
in FY12. It is also bidding for over MYR1.0 bln worth of new contracts  Risks to our recommendation and target price include: (i) failure to
and is confident of securing MYR100 mln-MYR150 mln worth of new replenish its orderbook that will hurt its future earnings, and (ii)
contracts to sustain its construction activities. unexpected rises in building materials cost affecting its margins.

Key Stock Statistics Per Share Data


FY Mar. 2010 2011E FY Mar. 2008 2009 2010 2011E
Reported EPS (sen) 7.6 7.8 Book Value (MYR) 2.08 2.05 2.09 2.12
PER (x) 11.1 10.7 Cash Flow (sen) 136.3 8.0 10.4 13.2
Dividend/Share (sen) 5.0 5.0 Reported Earnings (sen) 134.2 5.3 7.6 7.8
NTA/Share (MYR) 2.09 2.11 Dividend (sen) 10.0 5.0 5.0 5.0
Book Value/Share (MYR) 2.09 2.12 Payout Ratio (%) 5.4 69.9 46.0 44.9
No. of Outstanding Shares (mln) 113.9 PER (x) 0.6 15.9 11.1 10.7
52-week Share Price Range (MYR) 0.66 - 0.88 P/Cash Flow (x) 0.6 10.5 8.1 6.4
Major Shareholders: % P/Book Value (x) 0.4 0.4 0.4 0.4
Ideal Land Holdings Sdn Bhd 43.0 Dividend Yield (%) 11.9 6.0 6.0 6.0
Magnipact Resources Sdn Bhd 13.5 ROE (%) 93.1 2.6 3.7 3.7
*Stock deemed Shariah compliant by the Securities Commission Net Gearing (%) 18.6 36.0 46.3 57.7

All required disclosures and analyst certification appear on the last two pages of this report. Additional information is available upon request.
Redistribution or reproduction is prohibited without written permission. Copyright © 2010 The McGraw-Hill Companies, Inc. Page 1 of 4
Ireka Corporation
Recommendation: HOLD
Stock Code: 8834 Bloomberg: IREKA MK Price: MYR0.84 12-Month Target Price: MYR0.94 Date: July 26, 2010

Profit & Loss


FY Mar. / MYR mln 2009 2010 2011E 2012E
Reported Revenue 323.7 393.1 470.6 429.9
Reported Operating Profit 12.4 20.0 22.5 21.8
Depreciation & Amortization -3.1 -3.1 -3.2 -3.2
Net Interest Income / (Expense) -5.5 -7.0 -10.2 -10.2
Reported Pre-tax Profit 7.0 9.2 9.4 11.7
Effective Tax Rate (%) 13.5 5.0 5.0 5.0
Reported Net Profit 6.0 8.7 8.9 11.1
Reported Operating Margin (%) 3.8 5.1 4.8 5.1
Reported Pre-tax Margin (%) 2.2 2.3 2.0 2.7
Reported Net Margin (%) 1.9 2.2 1.9 2.6
Source: Company data, S&P Equity Research

All required disclosures and analyst certification appear on the last two pages of this report. Additional information is available upon request.
Redistribution or reproduction is prohibited without written permission. Copyright © 2010 The McGraw-Hill Companies, Inc. Page 2 of 4
Required Disclosures

Standard & Poor’s Equity Research Services Standard & Poor's and its affiliates provide a wide range of services to, or relating
Standard & Poor’s Equity Research Services U.S. includes Standard & Poor’s to, many organizations, including issuers of securities, investment advisers, broker-
Investment Advisory Services LLC; Standard & Poor’s Equity Research Services dealers, investment banks, other financial institutions and financial intermediaries,
Europe includes Standard & Poor’s LLC- London; Standard & Poor’s Equity and accordingly may receive fees or other economic benefits from those
Research Services Asia includes Standard & Poor’s LLC’s offices in Hong Kong organizations, including organizations whose securities or services they may
and Singapore, Standard & Poor’s Malaysia Sdn Bhd, and Standard & Poor’s recommend, rate, include in model portfolios, evaluate or otherwise address.
Information Services (Australia) Pty Ltd.
CMDF-Bursa Research Scheme (“CBRS”)
Glossary This report has been prepared by S&PM for purposes of CBRS administered by
Bursa Malaysia Berhad, independent from any influence from CBRS or the subject
Strong Buy: Total return is expected to outperform the total return of the KLCI or company. S&P will receive total compensation of RM15,000 each year for each
KL Emas Index respectively, by a wide margin over the coming 12 months, with company covered by it under CBRS. For more information about CBRS, please
shares rising in price on an absolute basis. visit Bursa Malaysia’s website at: http://www.bursamalaysia.com/website/bm/
Buy: Total return is expected to outperform the total return of the KLCI or KL Emas
Index respectively, over the coming 12 months, with shares rising in price on an Disclaimers
absolute basis.
Hold: Total return is expected to closely approximate the total return of the KLCI or This material is based upon information that we consider to be reliable, but neither
KL Emas Index respectively, over the coming 12 months with shares generally S&P nor its affiliates warrant its completeness, accuracy or adequacy and it should
rising in price on an absolute basis. not be relied upon as such. With respect to reports issued to clients in Japan and in
Sell: Total return is expected to underperform the total return of the KLCI or KL the case of inconsistencies between the English and Japanese version of a report,
Emas Index respectively, over the coming 12 months and share price is not the English version prevails. With respect to reports issued to clients in Germany
anticipated to show a gain. and in the case of inconsistencies between the English and German version of a
Strong Sell: Total return is expected to underperform the total return of the KLCI or report, the English version prevails. Neither S&P nor its affiliates guarantee the
KL Emas Index respectively, over the coming 12 months by a wide margin, with accuracy of the translation. Assumptions, opinions and estimates constitute our
shares falling in price on an absolute basis. judgment as of the date of this material and are subject to change without notice.
Neither S&P nor its affiliates are responsible for any errors or omissions or for
results obtained from the use of this information. Past performance is not
S&P 12 Month Target Price – The S&P equity analyst’s projection of the market necessarily indicative of future results.
price a given security will command 12 months hence, based on a combination of
intrinsic, relative, and private market valuation metrics. This material is not intended as an offer or solicitation for the purchase or sale of
any security or other financial instrument. Securities, financial instruments or
Shariah-compliant stock - As defined by the Shariah Advisory Council of strategies mentioned herein may not be suitable for all investors. Any opinions
Malaysia’s Securities Commission expressed herein are given in good faith, are subject to change without notice, and
are only correct as of the stated date of their issue. Prices, values, or income from
any securities or investments mentioned in this report may fall against the interests
Required Disclosures of the investor and the investor may get back less than the amount invested. Where
an investment is described as being likely to yield income, please note that the
All of the views expressed in this research report accurately reflect the amount of income that the investor will receive from such an investment may
research analyst's personal views regarding any and all of the subject fluctuate. Where an investment or security is denominated in a different currency to
securities or issuers. No part of analyst compensation was, is, or will be, the investor’s currency of reference, changes in rates of exchange may have an
directly or indirectly, related to the specific recommendations or views adverse effect on the value, price or income of or from that investment to the
expressed in this research report. investor. The information contained in this report does not constitute advice on the
tax consequences of making any particular investment decision. This material is not
Additional information is available upon request. intended for any specific investor and does not take into account your particular
investment objectives, financial situations or needs and is not intended as a
Other Disclosures recommendation of particular securities, financial instruments or strategies to you.
Before acting on any recommendation in this material, you should consider whether
This report has been prepared and issued by Standard & Poor’s and/or one of its it is suitable for your particular circumstances and, if necessary, seek professional
affiliates. In the United States, research reports are prepared by Standard & Poor’s advice.
Investment Advisory Services LLC (“SPIAS”). In the United States, research reports
are issued by Standard & Poor’s (“S&P”); in the United Kingdom by Standard & For residents of the U.K. This report is only directed at and should only be relied on
Poor’s LLC (“S&P LLC”), which is authorized and regulated by the Financial by persons outside of the United Kingdom or persons who are inside the United
Services Authority; in Hong Kong by Standard & Poor’s LLC, which is regulated by Kingdom and who have professional experience in matters relating to investments
the Hong Kong Securities Futures Commission; in Singapore by Standard & Poor’s or who are high net worth persons, as defined in Article 19(5) or Article 49(2) (a) to
LLC, which is regulated by the Monetary Authority of Singapore; in Malaysia by (d) of the Financial Services and Markets Act 2000 (Financial Promotion) Order
Standard & Poor’s Malaysia Sdn Bhd (“S&PM”), which is regulated by the 2005, respectively.
Securities Commission; in Australia by Standard & Poor’s Information Services
(Australia) Pty Ltd (“SPIS”), which is regulated by the Australian Securities & For residents of Singapore - Anything herein that may be construed as a
Investments Commission; and in Korea by SPIAS, which is also registered in Korea recommendation is intended for general circulation and does not take into account
as a cross-border investment advisory company. the specific investment objectives, financial situation or particular needs of any
particular person. Advice should be sought from a financial adviser regarding the
The research and analytical services performed by SPIAS, S&P LLC, S&PM, and suitability of an investment, taking into account the specific investment objectives,
SPIS are each conducted separately from any other analytical activity of Standard financial situation or particular needs of any person in receipt of the
& Poor’s. recommendation, before the person makes a commitment to purchase the
investment product.
A reference to a particular investment or security by Standard & Poor’s and/or one
of its affiliates is not a recommendation to buy, sell, or hold such investment or For residents of Malaysia. All queries in relation to this report should be referred to
security, nor is it considered to be investment advice. Alexander Chia, Desmond Ch’ng or Ching Wah Tam.
Indexes are unmanaged, statistical composites and their returns do not include
payment of any sales charges or fees an investor would pay to purchase the
securities they represent. Such costs would lower performance. It is not possible to
invest directly in an index.

Redistribution or reproduction is prohibited without written permission. Copyright © 2010 The McGraw-Hill Companies, Inc. Page 3 of 4
Required Disclosures

Recommendation and Target Price History P rice (M YR)


Date Recommendation Target Price 2.0
New Hold 0.94
3-Jun-10 Buy 0.88 1.8
9-Apr-10 Hold 0.88
2-Mar-10 Buy 0.88 1.6

1-Sep-09 Buy 0.85


1.4
29-May-09 Buy 0.84
27-Feb-09 Hold 0.65 1.2
2-Dec-08 Hold 0.90
2-Sep-08 Buy 1.20 1.0
30-Apr-08 Buy 1.30
0.8

0.6

0.4
Jul 07 Oct 07 Jan 08 Apr 08 Jul 08 Oct 08 Jan 09 Apr 09 Jul 09 Oct 09 Jan 10 Apr 10 Jul 10

Redistribution or reproduction is prohibited without written permission. Copyright © 2010 The McGraw-Hill Companies, Inc. Page 4 of 4

You might also like